| Literature DB >> 22808017 |
Gerry McCartney1, Martin Shipley, Carole Hart, George Davey-Smith, Mika Kivimäki, David Walsh, Graham C Watt, G David Batty.
Abstract
BACKGROUND: To examine explanations for the higher rates of male mortality in two Scottish cohorts compared with a cohort in south-east England for which similar data were collected. METHODOLOGY/PRINCIPALEntities:
Mesh:
Year: 2012 PMID: 22808017 PMCID: PMC3394776 DOI: 10.1371/journal.pone.0038860
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Proportions and means+ for established risk factors by study.
| Whitehall(n = 13,884) | Collaborative(n = 3,956) | Renfrew & Paisley(n = 6,813) | |
| Age (years) | 53.6 | 52.2 | 54.6 |
| Social class (%) | |||
| I, II | 72.7 | 30.4 | 19.3 |
| III NM | 16.9 | 16.9 | 11.6 |
| III M, IV, V | 10.4 | 52.8 | 69.0 |
| Plasma cholesterol (mmol/l) | 5.69 | 5.88 | 5.86 |
| Systolic blood pressure (mm Hg) | 137.4 | 137.5 | 147.6 |
| Diastolic blood pressure (mm Hg) | 85.0 | 84.9 | 85.8 |
| Body Mass Index (kg m−2) | 25.6 | 25.2 | 25.9 |
| Height (cm) | 172.9 | 171.9 | 169.7 |
| Smoking status (%): | |||
| Never | 17.0 | 15.0 | 16.8 |
| Ex | 37.3 | 27.3 | 24.3 |
| Current pipe or cigar smoker | 3.5 | 2.5 | 1.9 |
| Current cigarette smoker | 42.2 | 55.2 | 57.0 |
| Cigarettes per day (smokers only) | 16.1 | 18.8 | 20.5 |
| Forced Expiratory Volume in 1 second (FEV1) | |||
| Mean | 3.07 | 2.81 | 2.56 |
| Ratio to that predicted | 1.04 | 0.96 | 0.90 |
| Angina (%) | 5.3 | 7.7 | 8.9 |
| Possible MI (%) | 7.0 | 7.8 | 9.2 |
| ECG abnormalities (%) | 7.2 | 7.3 | 9.8 |
| Respiratory symptoms (%) | |||
| No winter phlegm | 76.4 | 69.8 | 63.5 |
| Persistent phlegm | 16.2 | 19.4 | 21.4 |
| Infective phlegm | 7.4 | 10.8 | 15.1 |
| Breathlessness (%) | 6.1 | 7.2 | 12.9 |
| MRC Chronic bronchitis (%) | 3.2 | 4.3 | 8.7 |
Prevalences and means are adjusted for age (age is unadjusted). All measures show significant (p<0.001) heterogeneity between the studies.
FEV ratio is the ratio of measured FEV divided by predicted FEV calculated from subjects’ age and height based on an equation derived in those men free of respiratory symptoms in the Renfrew & Paisley study.
Age adjusted mortality rates by study and time of follow-up.
| Follow-up period | ||||||||
| 0–9 years | 10–19 years | ≥20 years | Total | |||||
| Deaths | Rate | Deaths | Rate | Deaths | Rate | Deaths | Rate | |
| All causes | ||||||||
| Whitehall | 1,557 | 12.1 (0.3) | 2,793 | 28.0 (0.5) | 7,336 | 84.4 (1.2) | 11,686 | 35.8 (0.3) |
| Collaborative | 527 | 16.1 (0.8) | 897 | 36.0 (1.5) | 1,818 | 84.4 (1.0) | 3,242 | 38.7 (0.8) |
| Renfrew & Paisley | 1,327 | 19.9 (0.6) | 1,927 | 43.4 (1.6) | 2,457 | 90.6 (1.1) | 5,711 | 41.6 (0.6) |
| CHD | ||||||||
| Whitehall | 665 | 5.2 (0.2) | 969 | 9.6 (0.3) | 1,785 | 20.2 (0.6) | 3,419 | 10.6 (0.2) |
| Collaborative | 235 | 7.0 (0.5) | 346 | 13.4 (0.9) | 464 | 21.0 (1.4) | 1,045 | 12.4 (0.5) |
| Renfrew & Paisley | 554 | 8.4 (0.4) | 681 | 15.4 (0.6) | 596 | 21.6 (1.0) | 1,831 | 13.4 (0.3) |
| Stroke | ||||||||
| Whitehall | 84 | 0.7 (0.1) | 218 | 2.2 (0.2) | 783 | 9.4 (0.4) | 1,085 | 3.4 (0.1) |
| Collaborative | 41 | 1.4 (0.3) | 81 | 4.1 (0.6) | 229 | 10.8 (1.0) | 351 | 4.5 (0.3) |
| Renfrew & Paisley | 94 | 1.4 (0.1) | 192 | 4.4 (0.3) | 334 | 13.1 (0.8) | 620 | 4.5 (0.2) |
| Respiratory diseases | ||||||||
| Whitehall | 100 | 0.8 (0.1) | 284 | 3.0 (0.2) | 1,171 | 15.0 (0.5) | 1,555 | 4.9 (0.1) |
| Collaborative | 23 | 0.8 (0.2) | 74 | 3.2 (0.5) | 238 | 13.4 (1.3) | 335 | 4.3 (0.3) |
| Renfrew & Paisley | 104 | 1.5 (0.2) | 170 | 3.9 (0.3) | 324 | 12.9 (0.9) | 598 | 4.4 (0.2) |
| Lung Cancer | ||||||||
| Whitehall | 180 | 1.4 (0.1) | 264 | 2.7 (0.2) | 344 | 3.7 (0.2) | 788 | 2.5 (0.1) |
| Collaborative | 69 | 2.1 (0.3) | 90 | 3.6 (0.5) | 148 | 5.3 (0.5) | 307 | 3.5 (0.2) |
| Renfrew & Paisley | 185 | 2.8 (0.2) | 247 | 5.6 (0.4) | 182 | 6.2 (0.5) | 614 | 4.5 (0.2) |
| Accidents and suicide | ||||||||
| Whitehall | 178 | 1.4 (0.1) | 137 | 1.3 (0.1) | 88 | 1.0 (0.1) | 178 | 0.5 (0.1) |
| Collaborative | 68 | 1.7 (0.2) | 51 | 1.7 (0.3) | 33 | 1.3 (0.3) | 68 | 0.7 (0.1) |
| Renfrew & Paisley | 117 | 1.8 (0.2) | 81 | 1.8 (0.2) | 49 | 1.9 (0.3) | 117 | 0.9 (0.1) |
| Alcohol-related | ||||||||
| Whitehall | 390 | 3.0 (0.2) | 324 | 3.0 (0.2) | 219 | 2.4 (0.2) | 390 | 1.2 (0.1) |
| Collaborative | 156 | 3.9 (0.3) | 122 | 3.9 (0.4) | 77 | 3.0 (0.5) | 156 | 1.6 (0.2) |
| Renfrew & Paisley | 298 | 4.8 (0.3) | 215 | 4.8 (0.3) | 127 | 4.3 (0.4) | 298 | 2.2 (0.1) |
Rates are given as the number of deaths per 1,000 person-years at risk.
Hazard ratios for mortality in the Scottish cohorts compared to the Whitehall Study+ (reference) with successive adjustment for potential explanatory factors.
| Adjusted for | All-cause mortality | CHD mortality | Stroke mortality | Respiratory mortality | Lung cancer mortality | Mortality due to accidents and suicide | Alcohol-related mortality | |||||||
| Collaborative | Renfrew &Paisley | Collaborative | Renfrew &Paisley | Collaborative | Renfrew &Paisley | Collaborative | Renfrew &Paisley | Collaborative | Renfrew &Paisley | Collaborative | Renfrew &Paisley | Collaborative | Renfrew &Paisley | |
| HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | |
| Age | 1.25 (1.21,1.30) | 1.41 (1.36,1.45) | 1.32 (1.23,1.41) | 1.41 (1.33,1.50) | 1.55 (1.37,1.75) | 1.73 (1.57,1.92) | 1.05 (0.93,1.18) | 1.17 (1.07,1.29) | 1.65(1.45,1.89) | 1.98 (1.78,2.21) | 1.77 (1.33,2.36) | 2.00 (1.56,2.55) | 1.73 (1.44,2.09) | 2.28 (1.95,2.67) |
| Age, socio-economicposition | 1.08 (1.04,1.13) | 1.17 (1.12,1.21) | 1.17 (1.09,1.26) | 1.22 (1.14,1.31) | 1.45 (1.27,1.66) | 1.60 (1.42,1.80) | 0.78 (0.69,0.88) | 0.82 (0.73,0.92) | 1.16 (1.01,1.35) | 1.30 (1.14,1.47) | 1.56 (1.14,2.13) | 1.70 (1.27,2.27) | 1.47 (1.20,1.81) | 1.85 (1.53,2.24) |
| Age, smoking | 1.17 (1.13,1.22) | 1.30 (1.26,1.34) | 1.25 (1.17,1.34) | 1.33 (1.26,1.42) | 1.48 (1.31,1.67) | 1.63 (1.47,1.81) | 0.94 (0.83,1.06) | 1.03 (0.93,1.14) | 1.34 (1.17,1.53) | 1.55 (1.39,1.73) | 1.66 (1.24,2.21) | 1.86 (1.45,2.38) | 1.62 (1.34,1.96) | 2.09 (1.78,2.45) |
| Age, FEV1 | 1.14 (1.10,1.19) | 1.19 (1.15,1.23) | 1.22 (1.13,1.30) | 1.22 (1.15,1.30) | 1.46 (1.29,1.65) | 1.56 (1.40,1.73) | 0.81 (0.72,0.91) | 0.76 (0.69,0.84) | 1.42 (1.24,1.62) | 1.52 (1.36,1.70) | 1.64 (1.23,2.19) | 1.73 (1.34,2.23) | 1.59 (1.32,1.93) | 1.96 (1.66,2.30) |
| Age, cardio-respiratorysymptomsor history | 1.22 (1.18,1.27) | 1.31 (1.27,1.35) | 1.29 (1.20,1.38) | 1.30 (1.23,1.38) | 1.54 (1.36,1.74) | 1.67 (1.50,1.85) | 0.98 (0.87,1.11) | 0.99 (0.90,1.10) | 1.57 (1.37,1.79) | 1.79 (1.60,1.99) | 1.72 (1.29,2.29) | 1.85 (1.45,2.37) | 1.70 (1.40,2.05) | 2.13 (1.82,2.49) |
| Age, height | 1.25 (1.20,1.30) | 1.37 (1.33,1.42) | 1.30 (1.21,1.40) | 1.35 (1.28,1.44) | 1.53 (1.36,1.73) | 1.67 (1.51,1.86) | 1.03 (0.92,1.16) | 1.12 (1.01,1.23) | 1.65 (1.44,1.88) | 1.95 (1.75,2.18) | 1.74 (1.31,2.32) | 1.90 (1.48,2.43) | 1.70 (1.41,2.06) | 2.16 (1.84,2.53) |
| Age, bodymass index | 1.25 (1.20,1.30) | 1.39 (1.35,1.44) | 1.33 (1.24,1.43) | 1.38 (1.30,1.46) | 1.55 (1.37,1.75) | 1.71 (1.54,1.89) | 1.01 (0.90,1.14) | 1.19 (1.08,1.31) | 1.60 (1.40,1.83) | 2.02 (1.81,2.25) | 1.73 (1.30,2.30) | 2.02 (1.58,2.58) | 1.72 (1.42,2.07) | 2.26 (1.93,2.64) |
| Age, systolicand diastolicblood pressure | 1.26 (1.21,1.31) | 1.33 1.29,1.38) | 1.34 (1.25,1.43) | 1.28 (1.20,1.36) | 1.58 (1.40,1.79) | 1.56 (1.41,1.73) | 1.05 (0.93,1.18) | 1.15 (1.04,1.27) | 1.66 (1.45,1.89) | 1.98 (1.77,2.21) | 1.77 (1.33,2.35) | 2.15 (1.67,2.77) | 1.73 (1.44,2.09) | 2.30 (1.95,2.70) |
| Age, cholesterol | 1.24 (1.20,1.29) | 1.40 (1.35,1.44) | 1.28 (1.19,1.37) | 1.38 (1.30,1.46) | 1.55 (1.37,1.76) | 1.74 (1.57,1.93) | 1.07 (0.95,1.21) | 1.20 (1.09,1.32) | 1.70 (1.49,1.94) | 2.04 (1.83,2.27) | 1.79 (1.34,2.38) | 2.02 (1.58,2.58) | 1.77 (1.47,2.14) | 2.33 (1.99,2.73) |
| Multiply | 1.09 (1.05,1.14) | 1.07 (1.03,1.10) | 1.16 (1.08,1.25) | 1.01 (0.95,1.08) | 1.44 (1.28,1.64) | 1.36 (1.21,1.52) | 0.75 (0.67,0.85) | 0.70 (0.63,0.78) | 1.24 (1.08,1.42) | 1.38 (1.22,1.55) | 1.57 (1.18,2.11) | 1.78 (1.36,2.33) | 1.56 (1.29,1.89) | 1.88 (1.58,2.23) |
| Multiply | 1.03 (0.98,1.07) | 0.99 (0.95,1.03) | 1.11 (1.03,1.20) | 0.96 (0.89,1.03) | 1.45 (1.27,1.66) | 1.37 (1.21,1.55) | 0.70 (0.61,0.79) | 0.65 (0.58,0.73) | 1.06 (0.92,1.23) | 1.16 (1.01,1.33) | 1.51 (1.11,2.07) | 1.70 (1.25,2.30) | 1.46 (1.19,1.80) | 1.73 (1.42,2.11) |
+Analyses for all-cause mortality are based on 13,884, 3,956 and 6,813 men in the Whitehall, Collaborative and Renfrew & Paisley studies respectively. For cause-specific mortality the number of men in the analyses are 13,850, 3,948 and 6,792 respectively. The number of deaths is given in Table 2.
Angina, ECG abnormality, respiratory symptoms or breathlessness.
Multiply adjusted for :- age, smoking, FEV1, cardio-respiratory symptoms or history, height, systolic blood pressure, cholesterol, body mass index.
Proportions and means+ for established risk factors in the Whitehall, Collaborative and Renfrew & Paisley studies by social class.
| Social classes I & II | Social class III NM | Social classes IIIM, IV, V | |||||||
| Whitehall (N = 10114) | Collaborative (N = 1220) | Renfrew & Paisley (N = 1297) | Whitehall (N = 2333) | Collaborative (N = 664) | Renfrew & Paisley (N = 804) | Whitehall(N = 1437) | Collaborative (N = 2072) | Renfrew & Paisley (N = 4712) | |
| Age (years) | 52.6 | 51.8 | 54.0 | 55.4 | 52.5 | 55.3 | 57.1 | 52.3 | 54.7 |
| Plasma cholesterol (mmol/l) | 5.71 | 6.24 | 6.01 | 5.69 | 6.02 | 5.94 | 5.54 | 5.64 | 5.80 |
| Systolic blood pressure (mm Hg) | 137.2 | 134.2 | 146.9 | 137.7 | 136.2 | 148.0 | 138.9 | 139.6 | 147.8 |
| Diastolic blood pressure (mm Hg) | 84.9 | 83.9 | 85.8 | 84.9 | 84.2 | 85.9 | 85.7 | 85.6 | 85.9 |
| Body Mass Index (kg m−2) | 25.6 | 25.2 | 26.0 | 25.4 | 25.2 | 25.7 | 25.6 | 25.3 | 25.8 |
| Height (cm) | 173.6 | 174.8 | 171.8 | 171.4 | 172.7 | 171.3 | 170.7 | 170.0 | 168.8 |
| Smoking status (%): | |||||||||
| Never | 18.4 | 18.2 | 22.7 | 13.8 | 16.8 | 18.5 | 11.0 | 12.5 | 14.9 |
| Ex | 40.9 | 33.5 | 30.4 | 30.3 | 26.8 | 26.8 | 24.1 | 23.9 | 22.2 |
| Current pipe or cigar | 4.0 | 3.7 | 2.6 | 1.8 | 2.1 | 1.6 | 2.5 | 1.9 | 1.7 |
| Current cigarettes | 36.8 | 44.6 | 44.2 | 54.1 | 54.3 | 53.1 | 62.3 | 61.7 | 61.2 |
| Cigarettes per day (smokers only) | 16.0 | 20.0 | 21.2 | 16.3 | 18.0 | 20.0 | 16.3 | 18.5 | 20.4 |
| Forced Expiratory Volume in 1 second (FEV1) | |||||||||
| Mean | 3.18 | 3.10 | 2.80 | 2.85 | 2.89 | 2.65 | 2.74 | 2.63 | 2.47 |
| Ratio to that predicted | 1.06 | 1.02 | 0.96 | 0.98 | 0.98 | 0.91 | 0.95 | 0.92 | 0.88 |
| Angina (%) | 5.1 | 6.0 | 6.9 | 5.6 | 8.2 | 10.0 | 5.4 | 8.6 | 9.3 |
| Possible MI (%) | 6.7 | 5.6 | 8.0 | 6.7 | 8.9 | 9.7 | 9.2 | 8.6 | 9.5 |
| ECG abnormalities (%) | 6.8 | 6.1 | 9.7 | 7.9 | 8.9 | 10.6 | 9.1 | 7.4 | 9.6 |
| Respiratory symptoms (%) | |||||||||
| No winter phlegm | 79.4 | 77.3 | 72.3 | 70.4 | 69.5 | 70.0 | 66.2 | 65.7 | 60.4 |
| Persistent phlegm | 14.6 | 15.3 | 19.4 | 19.5 | 21.5 | 19.6 | 20.8 | 21.0 | 22.3 |
| Infective phlegm | 6.0 | 7.4 | 8.3 | 10.1 | 8.7 | 10.4 | 13.0 | 13.3 | 17.3 |
| Breathlessness (%) | 4.8 | 3.4 | 7.1 | 8.4 | 9.1 | 11.7 | 11.6 | 8.7 | 14.6 |
| MRC Chronic bronchitis (%) | 2.1 | 1.5 | 4.3 | 5.2 | 5.0 | 6.2 | 6.7 | 5.6 | 10.3 |
Prevalences and means are adjusted for age (age is unadjusted).
FEV ratio is the ratio of measured FEV divided by predicted FEV calculated from subjects’ age and height based on an equation derived in those men free of respiratory symptoms in the Renfrew & Paisley study.
Hazard ratios for all-cause mortality in the Scottish cohorts compared to the Whitehall Study+ (reference) separately by social class with successive adjustment for potential explanatory factors.
| Social classes I & II | Social class III NM | Social classes IIIM, IV, V | |||||||
| Whitehall | Collaborative | Renfrew & Paisley | Whitehall | Collaborative | Renfrew & Paisley | Whitehall | Collaborative | Renfrew & Paisley | |
|
| 10114 | 1220 | 1297 | 2333 | 664 | 804 | 1437 | 2072 | 4712 |
|
| 8251 | 923 | 1004 | 2097 | 560 | 681 | 1338 | 1759 | 4026 |
|
| |||||||||
|
| 1.0 | 1.09 (1.02,1.17) | 1.22 (1.14,1.30) | 1.0 | 1.03 (0.93,1.13) | 1.11 (1.01,1.21) | 1.0 | 1.06 (0.98,1.14) | 1.13 (1.06,1.21) |
|
| 1.0 | 1.03 (0.96,1.10) | 1.16 (1.08,1.24) | 1.0 | 1.00 (0.91,1.10) | 1.09 (1.00,1.20) | 1.0 | 1.07 (1.00,1.16) | 1.14 (1.07,1.22) |
|
| 1.0 | 1.05 (0.98,1.12) | 1.10 (1.02,1.17) | 1.0 | 1.03 (0.94,1.14) | 1.05 (0.96,1.14) | 1.0 | 1.01 (0.94,1.09) | 1.04 (0.97,1.11) |
|
| 1.0 | 1.09 (1.02,1.17) | 1.18 (1.10,1.26) | 1.0 | 1.02 (0.92,1.12) | 1.07 (0.98,1.17) | 1.0 | 1.04 (0.96,1.12) | 1.07 (1.01,1.15) |
|
| 1.0 | 1.09 (1.02,1.17) | 1.21 (1.13,1.29) | 1.0 | 1.03 (0.94,1.13) | 1.11 (1.01,1.21) | 1.0 | 1.05 (0.97,1.13) | 1.11 (1.04,1.18) |
|
| 1.0 | 1.10 (1.03,1.18) | 1.21 (1.13,1.29) | 1.0 | 1.02 (0.93,1.13) | 1.10 (1.01,1.21) | 1.0 | 1.06 (0.98,1.14) | 1.14 (1.07,1.21) |
|
| 1.0 | 1.11 (1.04,1.19) | 1.14 (1.07,1.22) | 1.0 | 1.03 (0.94,1.14) | 1.04 (0.96,1.14) | 1.0 | 1.06 (0.99,1.14) | 1.10 (1.03,1.17) |
|
| 1.0 | 1.06 (0.99,1.13) | 1.20 (1.12,1.28) | 1.0 | 1.01 (0.91,1.11) | 1.09 (1.00,1.19) | 1.0 | 1.05 (0.98,1.14) | 1.12 (1.05,1.20) |
|
| 1.0 | 1.00 (0.94,1.08) | 0.99 (0.93,1.06) | 1.0 | 0.96 (0.87,1.06) | 0.95 (0.86,1.04) | 1.0 | 1.04 (0.97,1.13) | 1.02 (0.95,1.09) |
Angina, ECG abnormality, respiratory symptoms or breathlessness.
Multiply adjusted for :- age, smoking, FEV1, cardio-respiratory symptoms or history, height, systolic blood pressure, cholesterol, body mass index.
Hazard ratios for all-cause mortality in the Scottish cohorts compared to the Whitehall Study+ (reference) by time of follow-up.
| Follow-up period 0–9 years | Follow-up period 10–19 years | Follow-up period 20+ years | |||||||
| Whitehall | Collaborative | Renfrew &Paisley | Whitehall | Collaborative | Renfrew &Paisley | Whitehall | Collaborative | Renfrew & Paisley | |
|
| 13884 | 3956 | 6813 | 12239 | 3417 | 5452 | 9375 | 2508 | 3515 |
|
| 1557 | 527 | 1327 | 2793 | 897 | 1927 | 7336 | 1818 | 2457 |
|
| |||||||||
|
| 1.0 | 1.45 (1.31,1.60) | 1.64 (1.53,1.77) | 1.0 | 1.40 (1.30,1.51) | 1.56 (1.47,1.65) | 1.0 | 1.15 (1.09,1.21) | 1.25 (1.19,1.21) |
|
| 1.0 | 1.20 (1.09,1.33) | 1.10 (1.01,1.19) | 1.0 | 1.21 (1.12,1.30) | 1.13 (1.07,1.22) | 1.0 | 1.02 (0.97,1.08) | 1.01 (0.96,1.07) |
|
| 1.0 | 1.10 (0.99,1.23) | 1.01 (0.92,1.11) | 1.0 | 1.13 (1.05,1.23) | 1.07 (0.99,1.15) | 1.0 | 0.96 (0.91,1.02) | 0.95 (0.89,1.00) |
Multiply adjusted for :- age, smoking, FEV1, cardio-respiratory symptoms or history, height, systolic blood pressure, cholesterol, body mass index.